Login / Signup

Patient-centered communication and shared decision making to reduce HbA1c levels of patients with poorly controlled type 2 diabetes mellitus - results of the cluster-randomized controlled DEBATE trial.

Anja WollnyAttila AltinerAnne DaubmannEva DrewelowChristian HelbigSusanne LöscherMichael PentzekSara SantosKarl WegscheiderStefan WilmChristin Löffler
Published in: BMC family practice (2019)
The trial was registered at ISRCTN registry under the reference ISRCTN70713571 .
Keyphrases
  • phase iii
  • phase ii
  • open label
  • clinical trial
  • study protocol
  • double blind
  • placebo controlled
  • randomized controlled trial
  • cardiovascular risk factors
  • cardiovascular disease
  • weight loss